$225.00
Dihexa is a research peptide known for its potential effects on cognitive function and synaptic connectivity. It was originally developed to explore compounds that may support learning and memory by influencing neurotrophic activity. Dihexa’s unique structure allows it to cross the blood–brain barrier and interact with pathways associated with brain performance and plasticity, making it a compound of interest in ongoing neurological research.
Dihexa Capsules 5mg is an advanced, high-purity oral neuropeptide research formulation designed to study profound synaptogenesis, dendritic spine growth, and cognitive repair. By acting as a potent HGF/c-Met receptor agonist that easily crosses the blood-brain barrier, this precise capsule format serves as a premier investigative tool for tracking enhanced synaptic connectivity, memory retention, and neuroprotective signaling in laboratory models.
Supplied as stable, precisely standardized 5mg research capsules. Restricted strictly to laboratory and in vitro evaluation.
Eterna Peptides presents premium-grade Dihexa Capsules (5mg), an advanced oral nootropic research formulation containing a highly purified synthetic peptide variant. Derived from angiotensin IV, Dihexa is celebrated within the neuroscience research community for its unmatched capacity to cross the blood-brain barrier and investigate profound synaptic connectivity, memory retention, and cellular brain repair kinetics.
Mechanism of Action
Dihexa operates via a highly distinct and potent neurobiological pathway to stimulate structural neuroplasticity:
* **HGF/c-Met Receptor Activation:** Dihexa binds with high affinity to Hepatocyte Growth Factor ($HGF$) and upregulates its receptor, $c-Met$. This signaling cascade is a master regulator of dendritic spine growth, cell survival, and tissue regeneration.
* **Synaptogenesis Catalyst:** Research indicates that Dihexa is exponentially more potent than native Brain-Derived Neurotrophic Factor ($BDNF$) at driving the formation of new synaptic connections (synaptogenesis) and reinforcing long-term potentiation ($LTP$).
* **Blood-Brain Barrier Bioavailability:** Unlike many traditional neurotrophic proteins that fail to cross central nervous system barriers, Dihexa’s unique small-molecule architecture allows for highly effective oral bioavailability and direct interaction with cerebral pathways.
Research Applications
In preclinical and in vitro laboratory models, Dihexa 5mg oral capsules are actively utilized to investigate:
* Enhanced cognitive repair models, memory retrieval mechanics, and spatial learning adaptations.
* Neurodegenerative progression mitigation, cellular survival rates, and axonal dendritic branching pathways.
* The recovery of synaptic signaling thresholds following chemical or metabolic neuronal disruption.
* The comparative baseline bioavailability of stabilized small-molecule neuropeptide capsules.
Our Dihexa capsules are manufactured under strict laboratory quality control guidelines to ensure absolute ingredient standardization, chemical purity, and dependable experimental reproducibility.
—
*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*
